Beijing Center for Disease Prevention and Control, Department of Bacteriology, Capital Institute of Pediatrics, No. 2 Yabao Road, Beijing 100020, People's Republic of China.
J Clin Microbiol. 2010 Dec;48(12):4567-72. doi: 10.1128/JCM.00400-10. Epub 2010 Sep 22.
Mycoplasma pneumoniae is usually susceptible to macrolides, but macrolide-resistant strains have been found frequently in recent years. Mutations in domain V of the 23S rRNA gene of M. pneumoniae interfere with the binding of macrolides to rRNA and mediate macrolide resistance. In this study, we developed a rapid and inexpensive method that combines nested PCR (nPCR), single-strand conformation polymorphisms (SSCPs), and capillary electrophoresis (CE) to detect macrolide-resistant mutants directly from throat swabs. nPCR was used to specifically amplify M. pneumoniae 23S rRNA gene fragments containing mutations, and amplicons were analyzed by CE-SSCP for macrolide resistance mutations, with results confirmed by sequencing. From January to December 2009, 665 throat swabs were collected in Beijing, China, yielding 110 samples that tested positive for M. pneumoniae by nPCR and serological testing. We randomly selected 64 positive throat swabs for CE-SSCP analysis. The A2063G mutation was found in 57 samples, and a coexisting T2611C mutation was identified in 1 sample. An A2063T mutation was identified in 1 sample. The total mutation rate was 91%. All mutant samples identified by nPCR-CE-SSCP were sequenced. The nPCR-CE-SSCP method could identify macrolide-resistant mutants directly from clinical samples. This is the first report of an nPCR-CE-SSCP assay for the detection of dominant mutations that confer macrolide resistance on M. pneumoniae. This approach would allow clinicians to choose appropriate therapy rapidly and could be used as a screening method for genetic mutations related to antibiotic resistance.
肺炎支原体通常对大环内酯类药物敏感,但近年来已发现大量大环内酯类耐药菌株。肺炎支原体 23S rRNA 基因结构域 V 的突变会干扰大环内酯类药物与 rRNA 的结合,并介导大环内酯类耐药。本研究建立了一种快速、经济的方法,结合巢式 PCR(nPCR)、单链构象多态性(SSCP)和毛细管电泳(CE),可直接从咽拭子中检测大环内酯类耐药突变体。nPCR 用于特异性扩增包含突变的肺炎支原体 23S rRNA 基因片段,并用 CE-SSCP 分析对大环内酯类耐药突变,测序结果进行确认。2009 年 1 月至 12 月,在中国北京采集了 665 份咽拭子,其中 110 份经 nPCR 和血清学检测为肺炎支原体阳性。我们随机选择了 64 份阳性咽拭子进行 CE-SSCP 分析。在 57 份样本中发现了 A2063G 突变,在 1 份样本中发现了同时存在的 T2611C 突变,在 1 份样本中发现了 A2063T 突变。总突变率为 91%。所有经 nPCR-CE-SSCP 鉴定的突变样本均进行了测序。nPCR-CE-SSCP 方法可直接从临床样本中鉴定大环内酯类耐药突变体。这是首次报道用于检测导致肺炎支原体大环内酯类耐药的优势突变的 nPCR-CE-SSCP 检测方法。该方法可使临床医生快速选择合适的治疗方法,也可用作与抗生素耐药相关的基因突变的筛查方法。